BIOFACTURA, INC. holds $24.0M across 1 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Mar 30, 2029 PoP end — agencies typically plan 12–18 months ahead.
EO14042 - THE ADVANCEMENT OF THE DEVELOPMENT OF A SMALLPOX BIODEFENSE THERAPEUTIC TO THE CLINICAL STAGE AS AN ANTIBODY-BASED COUNTERMEASURE
Current PoP ends Mar 30, 2029 (977 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Sep 30, 2027.
Track recompete timing in SCOUT →BIOFACTURA, INC. — $24.0M obligated across 1 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Live Demand-Fit + Displacement scoring, alerts on verdict flips, and watchlists. Free — no card required.
See all live recompete landscapes — who else is expiring, and where the openings are.
Open BIOFACTURA, INC.’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Register free to start exploring SCOUT →